Company record
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre.
Warning letters
-
DrugsMukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre
FDA warned clinical investigator Dr. Mukesh Chandre over informed consent failures in a doxorubicin liposome bioequivalence study.
High risk